Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Mezzion Pharma (140410 KS)
Watchlist
20
Analysis
Health Care
•
South Korea
Mezzion Pharma Co Ltd develops pharmaceutical products and out-licenses them to foreign countries including Canada, Mexico, Russia, and the United States. The Company's main products are for benign prostatic hyperplasia and erectile dysfunction.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Mezzion Pharma
•
17 Mar 2026 15:52
KOSDAQ150 Index Adhoc Rebalance: Curiox Bio (445680 KQ) To Replace Mezzion Pharma (140410 KQ)
Mezzion Pharma has been added to the Investment Attention list and will be deleted from the KOSDAQ150 Index. Curiox Biosystems will be added to the...
Brian Freitas
Follow
494 Views
Share
bullish
•
Mezzion Pharma
•
17 Mar 2026 10:54
•
Primer
Primer: Mezzion Pharma (140410 KS) - Mar 2026
Mezzion Pharma is a late-stage, single-asset biopharmaceutical company whose value is almost entirely dependent on the clinical and regulatory...
αSK
Follow
174 Views
Share
bearish
•
Quantitative Analysis
•
25 Mar 2026 07:05
KRX Short Interest Weekly (Mar 20th): Samsung F&M Insurance, SamsungElecMech, DWEC, Samsung SDI
We analyzed KRX short interest report for the past week and highlighted short interest changes in Samsung F&M Insurance, SamsungElecMech, DWEC,...
Ke Yan, CFA, FRM
Follow
213 Views
Share
bearish
•
Quantitative Analysis
•
23 Mar 2026 07:05
KRX Foreign Holding Weekly (Mar 20th): Samsung Electronics, Hyundai Motor, SK Hynix, KIA, ISUPETASYS
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Hyundai Motor, SK Hynix,...
Ke Yan, CFA, FRM
Follow
304 Views
Share
bearish
•
Hong Kong Exchanges and Clearing
•
04 Nov 2019 08:45
Stock Short Ideas Within an Index Long Environment
Positioning is quickly shifting to more index net longs and we are on the hunt for stock shorts in Asia given the more bullish Q4 seasonality and...
Thomas Schroeder
497 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x